Stage FocusSeed, Series A, Series B+
GeographyEurope, Japan
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtechHardware
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Newton Biocapital is a life sciences investment firm based in Brussels with a second office in Tokyo, co-founded by CEO Alain Parthoens and Goro Takeda. It invests across Europe and Japan, targeting chronic health conditions in oncology, autoimmune, neurological, metabolic, genetic, and infectious disease. The firm typically takes board seats, preferably as lead investor, and works closely with po...
Notable Investments
S
SANTEROS
Sequana MedicalN
NeuvasqE
EditForceP
Perseus ProteomicsA
AdipoPharmaC
CellaïonP
Prism BioLabD
DeuteroncologyA
Aboleris PharmaJ
J-PharmaD
Dim3Similar Funds
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A
UTEC
Tokyo, Japan
Pure DeepTechBiotechAIAdvanced MaterialsSeedSeries A
AP
AdBio Partners
Paris, France
Pure DeepTechBiotechSynthetic BiologyMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
BC
Boundary Capital
Northampton, United Kingdom
Pure DeepTechBiotechMedtechAdvanced MaterialsSeedSeries A
DC
Dynamk Capital
New York, United States
Pure DeepTechBiotechMedtechHardwareSeedSeries A